ATE473758T1 - Her-2/neu multipeptidimpfstoff - Google Patents
Her-2/neu multipeptidimpfstoffInfo
- Publication number
- ATE473758T1 ATE473758T1 AT06007834T AT06007834T ATE473758T1 AT E473758 T1 ATE473758 T1 AT E473758T1 AT 06007834 T AT06007834 T AT 06007834T AT 06007834 T AT06007834 T AT 06007834T AT E473758 T1 ATE473758 T1 AT E473758T1
- Authority
- AT
- Austria
- Prior art keywords
- new
- vaccine
- multipeptide vaccine
- multipeptide
- neu
- Prior art date
Links
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 title abstract 3
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 title abstract 3
- 229940035036 multi-peptide vaccine Drugs 0.000 title 1
- 229960005486 vaccine Drugs 0.000 abstract 2
- 108700020796 Oncogene Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001103—Receptors for growth factors
- A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55533—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55538—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06007834A EP1844788B1 (de) | 2006-04-13 | 2006-04-13 | HER-2/neu Multipeptidimpfstoff |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE473758T1 true ATE473758T1 (de) | 2010-07-15 |
Family
ID=37110206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06007834T ATE473758T1 (de) | 2006-04-13 | 2006-04-13 | Her-2/neu multipeptidimpfstoff |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20090269364A1 (de) |
| EP (2) | EP1844788B1 (de) |
| AT (1) | ATE473758T1 (de) |
| AU (1) | AU2007237491B2 (de) |
| CA (1) | CA2649013C (de) |
| DE (1) | DE602006015421D1 (de) |
| ES (1) | ES2348312T3 (de) |
| IL (1) | IL194162A (de) |
| WO (1) | WO2007118660A2 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0724357D0 (en) * | 2007-12-14 | 2008-01-23 | Glaxosmithkline Biolog Sa | Method for preparing protein conjugates |
| JP2010006705A (ja) * | 2008-06-13 | 2010-01-14 | Atlas Antibodies Ab | Ｈｅｒ２サブセット |
| WO2010057197A1 (en) | 2008-11-17 | 2010-05-20 | The Regents Of The University Of Michigan | Cancer vaccine compositions and methods of using the same |
| IN2012DN00446A (de) * | 2009-07-30 | 2015-05-15 | Pfizer Vaccines Llc | |
| EP2292258A1 (de) | 2009-08-18 | 2011-03-09 | Pevion Biotech Ltd. | Multiepitop-Impfstoff für Her2/neu-assoziierten Krebs |
| LT2782598T (lt) | 2011-11-23 | 2020-07-27 | In3Bio Ltd. | Rekombinantiniai baltymai ir jų terapinis panaudojimas |
| EP2809345A4 (de) * | 2012-02-03 | 2015-11-25 | Univ Emory | Immunstimulierende zusammensetzungen, teilchen damit und verwendungen im zusammenhang damit |
| ES2908071T3 (es) | 2015-04-17 | 2022-04-27 | Biolife Science Qld Ltd | Composición de vacuna y usos de la misma |
| WO2016184862A1 (en) * | 2015-05-18 | 2016-11-24 | Oncoqr Ml Gmbh | Her2/neu immunogenic composition |
| CN110709094A (zh) | 2017-02-03 | 2020-01-17 | 威斯康星州医药大学股份有限公司 | Kras肽疫苗组合物及其使用方法 |
| US20210346484A1 (en) | 2017-12-11 | 2021-11-11 | Medizinische Universitaet Wien | Method of producing a vaccine composition and uses thereof |
| US12016844B2 (en) | 2019-07-02 | 2024-06-25 | Virago Vax Inc. | Mammary tumor virus suppression |
| US12029783B2 (en) | 2019-07-02 | 2024-07-09 | Virago Vax Inc. | Mammary tumor virus vaccine |
| CA3145363A1 (en) * | 2019-07-02 | 2021-01-07 | Virago Vax Inc. | Mammary tumor virus vaccine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05117165A (ja) * | 1991-10-24 | 1993-05-14 | Masakazu Ueda | 抗癌剤 |
| US7060284B1 (en) * | 1999-08-03 | 2006-06-13 | The Ohio State University | Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| EP1236740B1 (de) * | 2001-02-28 | 2012-07-18 | Bio Life Science Forschungs- und Entwicklungsges.m.b.H. | Vakzine gegen Krebserkrankungen, die mit dem HER-2/neu Onkogen assoziiert sind |
| WO2002088171A2 (en) * | 2001-04-26 | 2002-11-07 | Avidia Research Institute | Combinatorial libraries of monomer domains |
-
2006
- 2006-04-13 AT AT06007834T patent/ATE473758T1/de active
- 2006-04-13 ES ES06007834T patent/ES2348312T3/es active Active
- 2006-04-13 EP EP06007834A patent/EP1844788B1/de active Active
- 2006-04-13 DE DE602006015421T patent/DE602006015421D1/de active Active
-
2007
- 2007-04-11 US US12/296,738 patent/US20090269364A1/en not_active Abandoned
- 2007-04-11 AU AU2007237491A patent/AU2007237491B2/en active Active
- 2007-04-11 CA CA2649013A patent/CA2649013C/en active Active
- 2007-04-11 WO PCT/EP2007/003226 patent/WO2007118660A2/en not_active Ceased
- 2007-04-11 EP EP07724167A patent/EP2004218A2/de not_active Withdrawn
-
2008
- 2008-09-17 IL IL194162A patent/IL194162A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP1844788B1 (de) | 2010-07-14 |
| US20090269364A1 (en) | 2009-10-29 |
| AU2007237491B2 (en) | 2012-11-01 |
| ES2348312T3 (es) | 2010-12-02 |
| EP2004218A2 (de) | 2008-12-24 |
| IL194162A (en) | 2014-04-30 |
| IL194162A0 (en) | 2011-08-01 |
| AU2007237491A1 (en) | 2007-10-25 |
| EP1844788A1 (de) | 2007-10-17 |
| DE602006015421D1 (de) | 2010-08-26 |
| CA2649013A1 (en) | 2007-10-25 |
| WO2007118660A2 (en) | 2007-10-25 |
| CA2649013C (en) | 2017-05-02 |
| WO2007118660A3 (en) | 2007-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL194162A0 (en) | Her-2/neu multi-peptide vaccine | |
| PH12014501083A1 (en) | Anticancer fusion protein | |
| ATE387233T1 (de) | Schutzhülse für nadeln mit absatz | |
| PH12013500714A1 (en) | Anticancer fusion protein | |
| CL2009001258A1 (es) | Polipeptido multivalente que comprende dos dominios de fibronectina tipo iii, ligados por un polipeptido de engarce basado en glicina-serina o glicina-prolina. | |
| WO2008046911A3 (en) | Novel human micrornas associated with cancer | |
| GT200600092A (es) | Alargar el tiempo hasta la progresion de la enfermedad o la supervivencia de los pacientes de cancer | |
| NZ611108A (en) | Methods of treating fgf21-associated disorders | |
| BRPI0807896A2 (pt) | Fórceps bipolares não-aderentes. | |
| CR9512A (es) | Metodos para el tratamiento de tumores de cerebro con anticuerpos | |
| EA200802170A1 (ru) | Лиофилизированная композиция терапевтического пептидного антитела | |
| EA201000327A1 (ru) | Белок | |
| BR112014019901A2 (pt) | proteínas de fator viii recombinante | |
| EA201000865A1 (ru) | Комбинация ингибиторов протеинтирозинфосфатазы и гормона роста человека, предназначенная для лечения атрофии мышц и родственных нарушений | |
| PL393578A1 (pl) | Przeciwnowotworowe białko fuzyjne | |
| WO2008136869A3 (en) | Methods and compositions related to targeting wounds, regenerating tissue, and tumors | |
| NZ604089A (en) | Multivalent glycopeptide constructs and uses thereof | |
| WO2008153933A3 (en) | Soluble her2 and her3 splice variant proteins, splice-switching oligonucleotides, and their use in the treatment of disease | |
| CY1116269T1 (el) | Χρηση μιας πρωτεϊνης απο λουπινο | |
| AR076892A1 (es) | Conjugados de albumina-peptido amiloide y usos de los mismos | |
| ATE538660T1 (de) | Verfahren zur herstellung eines weizenproteinhydrolysats | |
| PH12013501970A1 (en) | Anticancer fusion protein | |
| NZ601647A (en) | Variant hhip1 protein and methods and uses thereof | |
| WO2010052243A3 (en) | Neurotensin-derived branched peptides and uses thereof | |
| MX2010010177A (es) | Fragmentos de beta timosina mejorada. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1844788 Country of ref document: EP |